EvolutionaryScale
L7 · Models
scientific & causal modelsstartupprivateseries A
Open weight
EvolutionaryScale, founded by former Meta AI researchers, builds frontier protein-language models for generative biology. Biotech and pharma researchers use them to design novel proteins for drug discovery and materials science. It released ESM3 in June 2024 and shipped larger ESM model access through 2026.
Ecosystem functionApplies LLM-scale training to protein evolution rather than language, and is the reference point for the whole biology-model category.
Business modelBiology models and partnerships
Revenue—
Valuation—
Last round$142Mled by Nat Friedman, Daniel Gross and Lux Capital · 2024
Sources · 1 ↓
Suggest an editLast verified 2026-08-07